HKSE - Delayed Quote HKD

CARsgen Therapeutics Holdings Limited (2171.HK)

Compare
9.650 -0.030 (-0.31%)
At close: 4:08:20 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
25,813.000
--
Gross Profit
--
--
--
25,813.000
--
Operating Expense
784,677.000
784,677.000
802,281.000
613,039.000
348,668.000
Operating Income
-784,677.000
-784,677.000
-802,281.000
-587,226.000
-348,668.000
Net Non Operating Interest Income Expense
68,127.000
68,127.000
12,045.000
-1,258.000
-12,717.000
Pretax Income
-747,387.000
-747,387.000
-890,952.000
-4,736,778.000
-1,064,049.000
Tax Provision
407.000
407.000
1,295.000
7,645.000
--
Net Income Common Stockholders
-747,794.000
-747,794.000
-892,247.000
-4,744,423.000
-1,064,049.000
Diluted NI Available to Com Stockholders
-747,794.000
-747,794.000
-892,247.000
-4,744,423.000
-1,064,049.000
Basic EPS
-1.34
--
-1.62
-12.26
-1.88
Diluted EPS
--
--
-1.62
-12.26
-1.88
Basic Average Shares
558,055.224
--
550,769.753
386,835.000
567,346.696
Diluted Average Shares
558,055.224
--
550,769.753
386,835.000
567,346.696
Total Operating Income as Reported
-767,649.000
-767,649.000
-881,297.000
-573,905.000
-327,045.000
Rent Expense Supplemental
3,847.000
3,847.000
723.000
100.000
--
Total Expenses
784,677.000
784,677.000
802,281.000
613,039.000
348,668.000
Net Income from Continuing & Discontinued Operation
-747,794.000
-747,794.000
-892,247.000
-4,744,423.000
-1,064,049.000
Normalized Income
-747,794.000
-747,794.000
-892,247.000
-1,627,744.000
-339,762.000
Interest Income
72,791.000
72,791.000
27,566.000
9,611.000
763.000
Interest Expense
4,664.000
4,664.000
15,521.000
10,869.000
13,480.000
Net Interest Income
68,127.000
68,127.000
12,045.000
-1,258.000
-12,717.000
EBIT
-742,723.000
-742,723.000
-875,431.000
-4,725,909.000
-1,050,569.000
EBITDA
-655,328.000
-655,328.000
-793,898.000
-4,673,463.000
-1,010,460.000
Reconciled Depreciation
87,395.000
87,395.000
81,533.000
52,446.000
40,109.000
Net Income from Continuing Operation Net Minority Interest
-747,794.000
-747,794.000
-892,247.000
-4,744,423.000
-1,064,049.000
Total Unusual Items Excluding Goodwill
--
--
--
-4,155,572.000
-724,287.000
Total Unusual Items
--
--
--
-4,155,572.000
-724,287.000
Normalized EBITDA
-655,328.000
-655,328.000
-793,898.000
-517,891.000
-286,173.000
Tax Rate for Calcs
0.000
0.000
0.000
0.000
--
Tax Effect of Unusual Items
--
--
--
-1,038,893.000
--
12/31/2020 - 6/18/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
179.400
-4.37%
 
6660.HK AIM Vaccine Co., Ltd.
6.480
-1.37%
 
2162.HK Keymed Biosciences Inc.
34.550
-8.84%
 
1952.HK Everest Medicines Limited
49.000
+3.38%
 
9969.HK InnoCare Pharma Limited
6.150
-0.32%
 
9926.HK Akeso, Inc.
61.750
-2.99%
 
2157.HK Lepu Biopharma Co., Ltd.
2.650
+3.11%
 
3759.HK Pharmaron Beijing Co., Ltd.
13.900
-2.66%
 
1548.HK GENSCRIPT BIO
9.640
-4.55%
 
1167.HK JACOBIO-B
1.310
-5.07%